IHE News

News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].

For media inquiries, please contact John Sproule, Senior Policy Director at  [email protected]

Long COVID-19: The Pandemic after the Pandemic

Dr. Christopher McCabe participates in the Alberta Health Services webinar series related to Long COVID. Host Shawna Curry interviews Dr. McCabe, Isabel Henderson and Dr. Simon Decary, to explore where long COVID started, what we can learn from current research, and where long COVID might be headed. Dr. McCabe provides overview of economic modelling support the Institute of Health Economics provided to decision-makers during pandemic and also outlined the collaborative work across the country to prepare for the next pandemic and respond to ongoing pressures.   Link to webinar: https://tinyurl.com/5bkvn2cc For further information John Sproule, Senior Policy Director, Institute of Health Economics, Ph: 780-862-1905 Email: [email protected]
Read More

IHE Board names Interim CEO

Given the recent announcement regarding the end of a successful tenure for IHE CEO Dr. Chris McCabe (link), the Institute of Health Economics (IHE) Board of Directors has asked Dr. Kate Harback to take on the role of Acting CEO effective 1st August 2022, and then Interim CEO effective 1st September 2022.  Dr. Harback is currently the Director of Economics at the Institute (link). She will continue as the Interim CEO until the process for selection of the permanent CEO is complete.  A CEO Recruitment Committee has been struck as a sub-committee of the Institute of Health Economics Board, with representatives from the Government of Alberta, the University of Alberta and the University of Calgary. Announcements regarding the search and selection process will be communicated at a later date.  …
Read More

IHE CEO participates in Slovakia HTA Advisory Board

IHE CEO, Dr. Christopher McCabe, participates in the National Institute for Value and Technologies in Health Care’s (NIHO) Scientific Advisory Committee. NIHO is the national agency in Slovakia and is the newest member of the International Network of Agencies for Health Technology Assessment (INAHTA) which the IHE is honored to host the secretariat for. Dr. McCabe presented on “Research Oriented Market Access: A prospectively designed coverage with evidence development framework”. The meeting was held on July 1st 2022, in Bratislava, Slovakia. Link to Agenda for Scientific Advisory Agenda. For further informationJohn Sproule, Senior Policy Director, Institute of Health Economics,Ph: 780-862-1905Email: [email protected]
Read More

IHE Chief Executive Officer Update

IHE CEO, Dr, Christopher McCabe will end a successful tenure as IHE CEO and Executive Director effective August 31, 2022. Our Chief Executive Officer, Dr. Christopher McCabe, has informed the Board that he has accepted the post of Professor of Health Economics at Queen’s University Belfast and has therefore given notice of his intent to resign as CEO and Executive Director with effect from the 31st August 2022. Dr. McCabe will be joining Queen’s University Belfast (QUB) on 1st September 2022, where he will be part of QUB’s contribution to the Belfast City Region Deal supporting economic development in the life sciences sector. He will be cross-appointed between the Centre for Public Health in the School of Medicine, Dentistry and Biomedical Sciences and Queen’s Management School. He will continue…
Read More

IHE joins Global Partners in Announcing 2021 UNIVANTS Awards

The IHE is pleased to have collaborated with global health industry leaders in the UNIVANTS of Healthcare Excellence awards in laboratory medicine and to share in announcement of the 2021 award winners. The UNIVANTS of Healthcare Excellence Award Program announces 13 teams with 2021 recognition for achieving measuring better healthcare performance www.UnivantsHCE.com.  Foundational principles across all winning teams include “UNIFYING” across the care continuum for the development and implementation of “AVANT-GARDE” processes to enable measurable differences to clinical care.  The 2021 submissions included hospitals, commercial laboratories, reference laboratories, and clinics.  Applications included best practices across key areas of unmet needs with representation from every region of the…
Read More